A new generation of AI tools is changing how analysts and aid workers make sense of war in real time—if they can learn to trust what the models tell them.
With new NIH funding, Najib El-Sayed is repurposing cancer-fighting inhibitors to block the metabolic “off-switch” Leishmania uses to hijack the immune system.